TOBIRA THERAPEUTICS

tobira-therapeutics-logo

Tobira Therapeutics, Inc., a biotechnology company, engages in the research, discovery, acquisition, development, and commercialization of antiviral compounds for the treatment of life-threatening and life-altering infectious diseases. It develops TBR-652 and TBR-220 antagonists for the treatment of HIV/AIDS, hepatitis, and other associated infectious conditions. The company was founded in 2006 and is based in Princeton, New Jersey.

#People #Financial #Website #More

TOBIRA THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Founded:
2006-01-01

Address:
Manalapan, New Jersey, United States

Country:
United States

Website Url:
http://www.tobiratherapeutics.com

Total Employee:
11+

Status:
Closed

Contact:
16507453883

Email Addresses:
[email protected]

Total Funding:
99 M USD

Technology used in webpage:
SPF Domain Not Resolving Google Maps Microsoft Azure DNS Google Maps API Google Maps For Work ATT Cisco Ironport Cloud MarkMonitor DNS



Current Advisors List

jack-nielsen_image

Jack Nielsen Member of the Board of Directors @ Tobira Therapeutics
Board_member

daniel-turner_image

Daniel Turner Board of Director @ Tobira Therapeutics
Board_member

pierre-legault_image

Pierre Legault Member of the Board of Directors @ Tobira Therapeutics
Board_member
2015-01-01

debra-k-liebert_image

Debra K. Liebert Board Observer @ Tobira Therapeutics
Board_observer

Current Employees Featured

eckard-weber_image

Eckard Weber
Eckard Weber Founder @ Tobira Therapeutics
Founder

Founder


brian-halak_image

Brian Halak

eckard-weber_image

Eckard Weber

Stock Details


Company's stock symbol is NASDAQ:TBRA

Investors List

stonepine-capital_image

Stonepine Capital

Stonepine Capital investment in Convertible Note - Tobira Therapeutics

biotechnology-value-fund_image

Biotechnology Value Fund

Biotechnology Value Fund investment in Convertible Note - Tobira Therapeutics

abingworth-management_image

Abingworth

Abingworth investment in Convertible Note - Tobira Therapeutics

bvf-partners_image

BVF Partners

BVF Partners investment in Convertible Note - Tobira Therapeutics

oxford-finance-corporation_image

Oxford Finance LLC

Oxford Finance LLC investment in Debt Financing - Tobira Therapeutics

rmi-partners_image

RMI Partners

RMI Partners investment in Debt Financing - Tobira Therapeutics

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series B - Tobira Therapeutics

canaan-partners_image

Canaan Partners

Canaan Partners investment in Series B - Tobira Therapeutics

montreaux-equity-partners_image

Montreux Equity Partners

Montreux Equity Partners investment in Series B - Tobira Therapeutics

domain-associates_image

Domain Associates

Domain Associates investment in Series B - Tobira Therapeutics

Official Site Inspections

http://www.tobiratherapeutics.com Semrush global rank: 7.06 M Semrush visits lastest month: 209

Unable to get host informations!!!

Loading ...

More informations about "Tobira Therapeutics"

Tobira Therapeutics - Crunchbase Company Profile

Tobira Therapeutics, Inc., a biotechnology company, engages in the research, discovery, acquisition, development, and commercialization of antiviral compounds for the treatment of life-threatening and life-altering infectious โ€ฆSee details»

Tobira Therapeutics - PitchBook

Developer of antiviral compounds for treating human immunodeficiency virus (HIV) infection. The company develops TBR-652 and TBR-220 antagonists for the treatment of HIV or AIDS, โ€ฆSee details»

Tobira Therapeutics - LinkedIn

Tobiraโ€™s management team has extensive experience in developing and commercializing therapeutics for liver disease and HIV-1. The lead indication for CVC is non-alcoholic steatohepatitis, or...See details»

Tobira Therapeutics, Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Tobira Therapeutics, Inc. of South San Francisco, CA. Get the latest business insights from Dun & โ€ฆSee details»

Tobira Therapeutics Company Profile | Management and

Www.tobiratherapeutics.com Tobira Therapeutics Profile and History Tobira is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapies โ€ฆSee details»

Tobira Therapeutics - Products, Competitors, Financials, Employees ...

Tobira is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapies to treat liver disease, inflammation, fibrosis and HIV.See details»

Tobira Therapeutics Inc - Company Profile and News

Tobira Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on developing and commercializing innovative therapeutics to treat liver diseases, human โ€ฆSee details»

Tobira Therapeutics - EquityNet

Tobira Therapeutics, Inc., a biotechnology company, engages in the research, discovery, acquisition, development, and commercialization of antiviral compounds for the treatment of โ€ฆSee details»

Tobira Therapeutics: Contact Details and Business Profile

Tobira Therapeutics is a Biotechnology, Drug Manufacturing & Research, and Developing innovative therapeutics to treat liver disease, HIV, company_reader located in South San โ€ฆSee details»

Company Tobira Therapeutics Inc - MarketScreener.com

Tobira Therapeutics Inc: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: | NasdaqSee details»

Tobira Therapeutics Inc. Announces Senior Management Team

Jun 30, 2008ย ยท PRINCETON, N.J. and SAN DIEGO, June 30 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and โ€ฆSee details»

Tobira Therapeutics - Overview, News & Similar companies

Tobira Therapeutics contact info: Phone number: (650) 741-6625 Website: www.tobiratherapeutics.com What does Tobira Therapeutics do? Tobira is a clinical-stage โ€ฆSee details»

Tobira Therapeutics Management Team | Org Chart - RocketReach

Tobira Therapeutics employs 5 employees. The Tobira Therapeutics management team includes Angeline Shashlo (Sr. Vice President Regulatory Affairs and Quality Assurance), Rebecca โ€ฆSee details»

Tobira Therapeutics Inc. Completes $31 Million Series A ... - BioSpace

Aug 2, 2007ย ยท Tobira Therapeutics is a private biopharmaceutical company which is focused on developing and commercializing innovative antiviral compounds to treat HIV disease. The โ€ฆSee details»

Allergan to Acquire Tobira Therapeutics Expanding Global GI R&D ...

Sep 20, 2016ย ยท DUBLIN and SAN FRANCISCO, Sept. 20, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Tobira Therapeutics, Inc. โ€ฆSee details»

Tobira Therapeutics Inc. Raises $31 Million in Series B Financing

Sep 30, 2010ย ยท MANALAPAN, N.J.-- (BUSINESS WIRE)--Tobira Therapeutics Inc., a biopharmaceutical company focused on developing and commercializing innovative antiviral โ€ฆSee details»

Tobira Therapeutics Completes Financing and Merger with Regado ...

May 5, 2015ย ยท Tobira is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapies to treat liver disease, inflammation, fibrosis and HIV.See details»

Antoun Nabhan, JD, Joins Tobira Therapeutics Leadership Team

Apr 5, 2012ย ยท Tobira Therapeutics is a biopharmaceutical company focused on the development and commercialization of innovative therapies that address important and unmet medical โ€ฆSee details»

Tobira Therapeutics, Inc. (Tobira Therapeutics, Inc.) - ่ฏ็‰ฉ็ฎก็บฟ_ไธ“ โ€ฆ

Acetaminophen (APAP, paracetamol) poisoning is a leading cause of acute liver failure (ALF) in humans and induces hepatocyte necrosis, followed by activation of the innate immune system, โ€ฆSee details»

Tobira Therapeutics (TBRA) Stock Price, News & Analysis

6 days agoย ยท Tobira Therapeutics, Inc., formerly Regado Biosciences, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the development and โ€ฆSee details»

linkstock.net © 2022. All rights reserved